This is a regulatory disclosure made by Shilpa Medicare Limited to BSE Limited and the National Stock Exchange of India Limited, pursuant to Regulation 29 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
The disclosure intimates that a Meeting of the Board of Directors of the company is scheduled to be held on Thursday, 5 November 2026. The primary agenda for the meeting is to consider and approve the unaudited financial results of the Company, both on a Standalone and Consolidated basis, for the second quarter and half year ended 30th September 2026.
In compliance with the company's Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the company's securities was closed on 01 October 2026 and will remain closed until 7 November 2026 (both days inclusive).